Education
About Us
Working with TipRanks
Follow Us
BCAL Diagnostics Limited (AU:BDX)
:BDX
RESEARCH TOOLSreports
Total Valuation
BCAL Diagnostics Limited has a market cap or net worth of AU$27.45M. The enterprise value is AU$27.07M.
Market CapAU$27.45M
Enterprise ValueAU$27.07M
Share Statistics
BCAL Diagnostics Limited has 365,967,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding365,967,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BCAL Diagnostics Limited’s return on equity (ROE) is -0.75 and return on invested capital (ROIC) is -36.49%.
Return on Equity (ROE)-0.75
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-36.49%
Return on Capital Employed (ROCE)-0.56
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.25
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BCAL Diagnostics Limited is -5.38. BCAL Diagnostics Limited’s PEG ratio is -0.65.
PE Ratio-5.38
PS Ratio0.00
PB Ratio4.01
Price to Fair Value4.01
Price to FCF-6.07
Price to Operating Cash Flow-7.62
PEG Ratio-0.65
Income Statement
In the last 12 months, BCAL Diagnostics Limited had revenue of 3.10M and earned -6.40M in profits. Earnings per share was -0.03.
Revenue3.10M
Gross Profit3.10M
Operating Income-5.45M
Pretax Income-9.45M
Net Income-6.40M
EBITDA-5.67M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -6.31M and capital expenditures -1.76M, giving a free cash flow of -8.07M billion.
Operating Cash Flow-6.31M
Free Cash Flow-8.07M
Free Cash Flow per Share-0.02
Dividends & Yields
BCAL Diagnostics Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.11
52-Week Price Change-11.11%
50-Day Moving Average0.10
200-Day Moving Average0.11
Relative Strength Index (RSI)38.45
Average Volume (3m)184.07K
Important Dates
BCAL Diagnostics Limited upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.
Last Earnings DateFeb 19, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend Date―
Financial Position
BCAL Diagnostics Limited as a current ratio of 3.60, with Debt / Equity ratio of 14.07%
Current Ratio3.60
Quick Ratio3.60
Debt to Market Cap0.02
Net Debt to EBITDA0.87
Interest Coverage Ratio-54.51
Taxes
In the past 12 months, BCAL Diagnostics Limited has paid -3.05M in taxes.
Income Tax-3.05M
Effective Tax Rate0.32
Enterprise Valuation
BCAL Diagnostics Limited EV to EBITDA ratio is -5.21, with an EV/FCF ratio of -5.20.
EV to Sales9.53
EV to EBITDA-5.21
EV to Free Cash Flow-5.20
EV to Operating Cash Flow-6.53
Balance Sheet
BCAL Diagnostics Limited has AU$7.01M in cash and marketable securities with AU$1.30M in debt, giving a net cash position of -AU$5.71M billion.
Cash & Marketable SecuritiesAU$7.01M
Total DebtAU$1.30M
Net Cash-AU$5.71M
Net Cash Per Share-AU$0.02
Tangible Book Value Per ShareAU$0.03
Margins
Gross margin is 100.00%, with operating margin of -175.82%, and net profit margin of -206.58%.
Gross Margin100.00%
Operating Margin-175.82%
Pretax Margin-304.93%
Net Profit Margin-206.58%
EBITDA Margin-182.91%
EBIT Margin-194.54%
Analyst Forecast
The average price target for BCAL Diagnostics Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-17.26%